The recent drop in drug overdose deaths, particularly from opioids, has been seen as a sign of progress in tackling the epidemic. This decline can be attributed to increased availability of naloxone and opioid treatments, as well as potentially changing street drug quality. However, experts warn that the data varies by state, showing staggered reductions and suggesting a need for ongoing efforts to understand the dynamics behind these changes and to ensure continuing support for those in need. Policy implications from the Trump administration warrant careful consideration as they could affect this progress.
People working on the ground and studying interventions all agree that making naloxone (Narcan), which can reverse an overdose, widely available and increasing access to treatments like buprenorphine and suboxone have been critical to saving lives.
Some experts point to the depressing possibility that many of the most at-risk people succumbed to an overdose earlier in the epidemic.
Collection
[
|
...
]